Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition
- Status
- RECRUITING
- Phase
- PHASE3
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
- Status
- TERMINATED
- Phase
- PHASE2
d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
- Status
- RECRUITING
- Phase
- PHASE2
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
- Status
- TERMINATED
- Phase
- PHASE2
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3